HOME > 研究業績 > 論文 2015


論文 2015年

  • Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, Mason N, Tong L, Locatelli F, Marshall MR, Inaba M and Robinson BM: Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int 2015;87:162-168
  • Emoto M, Terauchi Y, Ozeki A, Oura T, Takeuchi M, Imaoka T: A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial. Endocr J 2015;62:1101-1114
  • Fukuda S, Koyama H, Kondo K, Fujii H, Hirayama Y, Tabata T, Okamura M, Yamakawa T, Okada S, Hirata S, Kiyama H, Kajimoto O, Watanabe Y, Inaba M, Nishizawa Y. Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial. PLoS One 2015;10:e0119578
  • Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, Kimura K, Suzuki Y, Wada T, Ogawa S, Inaba M, Kanno Y, Shigematsu T, Masakane I, Tsuchiya K, Honda K, Ichikawa K, Shide K: A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
    Clin Exp Nephrol 2015;19:1-5
  • Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, Kimura K, Suzuki Y, Wada T, Ogawa S, Inaba M, Kanno Y, Shigematsu T, Masakane I, Tsuchiya K, Honda K, Ichikawa K, Shide K; Joint Committee on Diabetic Nephropathy A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. J Diabetes Investig 2015;6:242-6
  • Imamura S, Morioka T, Yamazaki Y, Numaguchi R, Urata H, Motoyama K, Mori K, Fukumoto S, Shoji T, Emoto M and Inaba M: Response to comment on Imamura et al. Plasma polyunsaturated fatty acid profile and delta-5 desaturase activity are altered in patients with type 2 diabetes. Metabolism 2014;63(11):1432-8. Metabolism, 2015;64:e3-4 
  • Inaba M. Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients. Contrib Nephrol 2015;185:15-21
  • Inaba M, Okuno S, Nagayama H, Yamada S, Ishimura E, Imanishi Y and Shoji S: Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone. J Ren Nutr 2015;25:242-246
  • Kadoya M, Koyama H, Kurajoh M, Kanzaki A, Kakutani-Hatayama M, Okazaki H, Shoji T, Moriwaki Y, Yamamoto T, Emoto M, Inaba M and Namba M: Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study. Atherosclerosis 2015;238:409-414
  • Kakutani Y, Shioi A, Shoji T, Okazaki H, Koyama H, Emoto M, Inaba M. Oncostatin M Promotes Osteoblastic Differentiation of Human Vascular Smooth Muscle Cells Through JAK3-STAT3 Pathway. J Cell Biochem 2015;116:1325-33
  • Katayama H, Tachibana D, Hamuro A, Misugi T, Motoyama K, Morioka T, Fukumoto S, Emoto M, Inaba M, Koyama M: Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum. Jpn Clin Med 2015;6:35-39
  • Kurajoh M, Koyama H, Kadoya M, Naka M, Miyoshi A, Kanzaki A, Kakutani-Hatayama M, Okazaki H, Shoji T, Moriwaki Y, Yamamoto T, Emoto M, Inaba M, Namba M. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol 2015;14:117
  • Matsufuji S, Shoji T, Yano Y, Tsujimoto Y, Kishimoto H, Tabata T, Emoto M and Inaba M. Effect of chair stand exercise on activity of daily living: a randomized controlled trial in hemodialysis patients. J Ren Nutr 2015;25:17-24
  • Mishima T, Motoyama K, Imanishi Y, Hamamoto K, Nagata Y, Yamada S, Kuriyama N, Watanabe Y, Emoto M, Inaba M. Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m2. Osteoporos Int 2015;26:229-36
  • Naganuma T, Takemoto Y, Shoji T, Ishimura E, Okamura M, Nakatani T: Cerebral microbleeds predict intracerebral hemorrhage in hemodialysis patients. Stroke 2015;46:2107-2112 - 30 -
  • Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K, Shoji S, Koyama H and Okuno S: Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 2015;26:1053-1061
  • Nakao T, Inaba M, Abe M, Kaizu K, Shima K, Babazono T, Tomo T, Hirakata H, Akizawa T, Japanese Society for Dialysis T: Best practice for diabetic patients on hemodialysis 2012. Ther Apher Dial 2015;19 Suppl 1:40-66
  • Nakatani S, Nakatani A, Tsugawa N, Yamada S, Mori K, Imanishi Y, Ishimura E, Okano T, Inaba M. Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m². Nephron 2015;130:119-26
  • Numaguchi R, Morioka T, Yamazaki Y, Imamura S, Urata H, Motoyama K, Mori K, Fukumoto S, Shoji T, Emoto M, Inaba M: Leptin is Associated with Local Stiffness of the Carotid Artery in Overweight Patients with Type 2 Diabetes. J Diabetes Metab 2015;6:627
  • Ochi A, Mori K, Nakatani S, Emoto M, Morioka T, Motoyama K, Fukumoto S, Imanishi Y, Shoji T, Ishimura E, Inaba M. Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells. Nephrol Dial Transplant 2015;30:1683-92
  • Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A; MUSASHI Study Investigators. Results of switching from intravenous to subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis: Extension of the MUSASHI study. Arthritis Care Res (Hoboken) 2015;67:1354-62
  • Ohara M, Imanishi Y, Nagata Y, Ishii A, Kobayashi I, Mori K, Ito M, Miki T, Nishizawa Y and Inaba M: Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone. J Bone Miner Metab 2015;33:584-590
  • Shoji T, Emoto M, Nishizawa Y, Inaba M: Endocrine and metabolic changes affecting cardiovascular disease in dialysis patients. J Ren Nutr 2015;25:223-5
  • Shoji T, Inaba M, Nishizawa Y: Vitamin D receptor activator and prevention of cardiovacular events in hemodialysis patients --- rationale and design of the Japan Dialysis Active Vitamin D (J-DAVID) trial. Renal Replacement Therapy 2016;2: 19
  • Tateishi Y, Osada-Oka M, Tanaka M, Shiota M, Izumi Y, Ishimura E, Motoyama K, Inaba M and Miura K: Myeloid HIF-1 attenuates the progression of renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci 2015;127:181-189
  • Uedono H, Tsuda A, Ishimura E, Yasumoto M, Ichii M, Ochi A, Ohno Y, Nakatani S, Mori K, Uchida J, Nakatani T, Inaba M. Relationship between serum uric acid levels and intrarenal hemodynamic parameters. Kidney Blood Press Res 2015;40:315-22
  • Urata H, Mori K, Emoto M, Yamazaki Y, Motoyama K, Morioka T, Fukumoto S, Koyama H, Shoji T, Ishimura E and Inaba M: Advantage of insulin glulisine over regular insulin in patients with type 2 diabetes and severe renal insufficiency. J Ren Nutr 2015;25:129-134
  • Wada N, Mori K, Nakagawa C, Sawa J, Kumeda Y, Shoji T, Emoto M, Inaba M. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring. J Diabetes Complications 2015 (in press)
  • Yamamoto T, Hidaka Y, Inaba M, Ishimura E, Ooyama H, Kakuta H, Moriwaki Y, Higami K, Ohtawara A, Hosoya T, Nishikawa H, Taniguchi A, Ueda T, Yamauchi T, Fujimori S, Mineo I, Yamanaka H. Effects of febuxostat on serum urate level in Japanese hyperuricemia patients. Mod Rheumatol 2015;25:779-83
  • Yasumoto M, Tsuda A, Ishimura E, Uedono H, Ohno Y, Ichii M, Ochi A, Nakatani S, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M. Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects - study of inulin and para-aminohippuric acid clearance in humans. Physiol Rep 2015;3:e12321
  • Yoda M, Imanishi Y, Nagata Y, Ohara M, Yoda K, Yamada S, Mori K, Inaba M. Teriparatide Therapy Reduces Serum Phosphate and Intima-Media Thickness at the Carotid Wall Artery in Patients with Osteoporosis. Calcif Tissue Int 2015;97:32-9.
  • Yoda K, Inaba M, Hamamoto K, Yoda M, Tsuda A, Mori K, Imanishi Y, Emoto M and Yamada S: Association between poor glycemic control, impaired sleep quality, and increased arterial thickening in type 2 diabetic patients. PLoS One 2015;10:e0122521
  • Yokoyama H, Okazaki K, Imai D, Yamashina Y, Takeda R, Naghavi N, Ota A, Hirasawa Y, Miyagawa T. The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid β peptide 42/40 ratio in healthy elderly persons: a randomized controlled trial. BMC Geriatr 2015;15: 60
  • Yokoyama H, Emoto M. Exercise capacity of patients with type 2 diabetes: a mini review of clinical findings. J Endocrinol Diab 2015;2: 1-5